BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31304601)

  • 1. Long noncoding RNA HCG22 suppresses proliferation and metastasis of bladder cancer cells by regulation of PTBP1.
    Jiang D; Zhang Y; Yang L; Lu W; Mai L; Guo H; Liu X
    J Cell Physiol; 2020 Feb; 235(2):1711-1722. PubMed ID: 31304601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lowly expressed lncRNA PVT1 suppresses proliferation and advances apoptosis of glioma cells through up-regulating microRNA-128-1-5p and inhibiting PTBP1.
    Dahai Z; Daliang C; Famu L; Xiang W; Lenian L; Jianmin C; Xiaobing X
    Brain Res Bull; 2020 Oct; 163():1-13. PubMed ID: 32562719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA circRHOBTB3 represses metastasis by regulating the HuR-mediated mRNA stability of PTBP1 in colorectal cancer.
    Chen J; Wu Y; Luo X; Jin D; Zhou W; Ju Z; Wang D; Meng Q; Wang H; Fu X; Xu J; Song Z
    Theranostics; 2021; 11(15):7507-7526. PubMed ID: 34158864
    [No Abstract]   [Full Text] [Related]  

  • 4. The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants and Predicts Poor Prognosis in Patients with Non-muscle-Invasive Bladder Cancer.
    Bielli P; Panzeri V; Lattanzio R; Mutascio S; Pieraccioli M; Volpe E; Pagliarulo V; Piantelli M; Giannantoni A; Di Stasi SM; Sette C
    Clin Cancer Res; 2018 Nov; 24(21):5422-5432. PubMed ID: 30012566
    [No Abstract]   [Full Text] [Related]  

  • 5. A Novel Combination RNAi toward Warburg Effect by Replacement with miR-145 and Silencing of PTBP1 Induces Apoptotic Cell Death in Bladder Cancer Cells.
    Takai T; Yoshikawa Y; Inamoto T; Minami K; Taniguchi K; Sugito N; Kuranaga Y; Shinohara H; Kumazaki M; Tsujino T; Takahara K; Ito Y; Akao Y; Azuma H
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A feedback loop between NONHSAT024276 and PTBP1 inhibits tumor progression and glycolysis in HCC by increasing the PKM1/PKM2 ratio.
    Li Y; Chen X; Huang H; Liao L; Chong H; Li G; Yuan T; Lu W; Deng S; Huang Q
    Cancer Sci; 2023 Apr; 114(4):1519-1540. PubMed ID: 36529521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM.
    Xie R; Chen X; Chen Z; Huang M; Dong W; Gu P; Zhang J; Zhou Q; Dong W; Han J; Wang X; Li H; Huang J; Lin T
    Cancer Lett; 2019 May; 449():31-44. PubMed ID: 30742945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNHG16 regulates invasion and migration of bladder cancer through induction of epithelial-to-mesenchymal transition.
    Chen W; Jiang T; Mao H; Gao R; Zhang H; He Y; Liu C; Chen Q
    Hum Cell; 2020 Jul; 33(3):737-749. PubMed ID: 32207096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non‑coding RNA HOTTIP enhances the fibrosis of lung tissues by regulating the miR‑744‑5p/PTBP1 signaling axis.
    Li J; Chai W; Zhao Z; Zhou Y; Wu Q
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34212978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53-targeted lncRNA ST7-AS1 acts as a tumour suppressor by interacting with PTBP1 to suppress the Wnt/β-catenin signalling pathway in glioma.
    Sheng J; He X; Yu W; Chen Y; Long Y; Wang K; Zhu S; Liu Q
    Cancer Lett; 2021 Apr; 503():54-68. PubMed ID: 33476649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA HOTTIP facilitates cell proliferation, invasion, and migration in osteosarcoma by interaction with PTBP1 to promote KHSRP level.
    Yao XY; Liu JF; Luo Y; Xu XZ; Bu J
    Cell Cycle; 2021 Feb; 20(3):283-297. PubMed ID: 33475442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTBP1 promotes the growth of breast cancer cells through the PTEN/Akt pathway and autophagy.
    Wang X; Li Y; Fan Y; Yu X; Mao X; Jin F
    J Cell Physiol; 2018 Nov; 233(11):8930-8939. PubMed ID: 29856478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINC01106 post-transcriptionally regulates ELK3 and HOXD8 to promote bladder cancer progression.
    Meng L; Xing Z; Guo Z; Liu Z
    Cell Death Dis; 2020 Dec; 11(12):1063. PubMed ID: 33311496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
    Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
    J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC00978 promotes bladder cancer cell proliferation, migration and invasion by sponging miR‑4288.
    Wang W; Xu Z; Wang J; Chen R
    Mol Med Rep; 2019 Aug; 20(2):1866-1872. PubMed ID: 31257499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA SFTA1P promotes cervical cancer progression by interaction with PTBP1 to facilitate TPM4 mRNA degradation.
    Luo A; Lan X; Qiu Q; Zhou Q; Li J; Wu M; Liu P; Zhang H; Lu B; Lu Y; Lu W
    Cell Death Dis; 2022 Nov; 13(11):936. PubMed ID: 36344495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncARSR sponges miR-129-5p to promote proliferation and metastasis of bladder cancer cells through increasing SOX4 expression.
    Liao C; Long Z; Zhang X; Cheng J; Qi F; Wu S; Huang T
    Int J Biol Sci; 2020; 16(1):1-11. PubMed ID: 31892841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skipping of exon 10 in
    Shen L; Lei S; Zhang B; Li S; Huang L; Czachor A; Breitzig M; Gao Y; Huang M; Mo X; Zheng Q; Sun H; Wang F
    Theranostics; 2020; 10(13):5719-5735. PubMed ID: 32483414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA MAGI2-AS3 inhibits bladder cancer progression by targeting the miR-31-5p/TNS1 axis.
    Tang C; Cai Y; Jiang H; Lv Z; Yang C; Xu H; Li Z; Li Y
    Aging (Albany NY); 2020 Nov; 12(24):25547-25563. PubMed ID: 33231563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells.
    Minami K; Taniguchi K; Sugito N; Kuranaga Y; Inamoto T; Takahara K; Takai T; Yoshikawa Y; Kiyama S; Akao Y; Azuma H
    Oncotarget; 2017 May; 8(20):33064-33077. PubMed ID: 28380435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.